Log in

NASDAQ:KBLMKBL MERGER CORP/SH Stock Price, Forecast & News

$10.98
+0.05 (+0.46 %)
(As of 08/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$10.98
Now: $10.98
$10.98
50-Day Range
$10.80
MA: $10.95
$11.13
52-Week Range
$9.43
Now: $10.98
$11.50
Volume334 shs
Average Volume2,539 shs
Market Capitalization$48.53 million
P/E RatioN/A
Dividend YieldN/A
Beta0.19
KBL Merger Corp. IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal reimbursement risk the firm focuses on retail healthcare, wellness and preventative care. In devices and diagnostics the firm focuses on medical devices, diagnostics, genetic testing and lab tools. The firm typically invests in firms located in the United States. The firm seeks to invest in firms with valuation between $200 million to $700 million and EBITDA between $20 million to $70 million. The firms invest in firms with enterprise value $200 million to $700 million. The firm seeks to take majority stakes. KBL Merger Corp. IV was founded in 2016 and is New York, New York with an additional office in Newark, Delaware.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.58 out of 5 stars


Industry, Sector and Symbol

Industry Holding & other investment offices
Sub-IndustryN/A
Current SymbolNASDAQ:KBLM
CUSIPN/A
Phone302-502-2727

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$1.12 per share

Profitability

Net Income$-90,000.00

Miscellaneous

EmployeesN/A
Market Cap$48.53 million
Next Earnings DateN/A
OptionableNot Optionable
$10.98
+0.05 (+0.46 %)
(As of 08/6/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KBLM News and Ratings via Email

Sign-up to receive the latest news and ratings for KBLM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











KBL MERGER CORP/SH (NASDAQ:KBLM) Frequently Asked Questions

How has KBL MERGER CORP/SH's stock been impacted by COVID-19 (Coronavirus)?

KBL MERGER CORP/SH's stock was trading at $10.58 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, KBLM stock has increased by 3.8% and is now trading at $10.98.
View which stocks have been most impacted by Coronavirus
.

Has KBL MERGER CORP/SH been receiving favorable news coverage?

Media stories about KBLM stock have been trending positive this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. KBL MERGER CORP/SH earned a daily sentiment score of 2.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term.
View the latest news about KBL MERGER CORP/SH
.

Who are some of KBL MERGER CORP/SH's key competitors?

What other stocks do shareholders of KBL MERGER CORP/SH own?

Who are KBL MERGER CORP/SH's key executives?

KBL MERGER CORP/SH's management team includes the following people:
  • Dr. Marlene R. Krauss M.D., CEO & Director (Age 73)
  • Mr. Joseph A. Williamson, COO & Director (Age 66)
  • Dr. Jean-Pierre Garnier Ph.D., Scientific Advisor (Age 72)
  • Dr. Myron L. Weisfeldt, Scientific Advisor
  • Dr. Phyllis I. Gardner, Scientific Advisor (Age 68)

What is KBL MERGER CORP/SH's stock symbol?

KBL MERGER CORP/SH trades on the NASDAQ under the ticker symbol "KBLM."

Who are KBL MERGER CORP/SH's major shareholders?

KBL MERGER CORP/SH's stock is owned by many different institutional and retail investors. Top institutional shareholders include Mizuho Securities USA LLC (5.74%). Company insiders that own KBL MERGER CORP/SH stock include Mizuho Securities Usa Llc and Oxford Asset Management Llp.
View institutional ownership trends for KBL MERGER CORP/SH
.

Which institutional investors are selling KBL MERGER CORP/SH stock?

KBLM stock was sold by a variety of institutional investors in the last quarter, including Mizuho Securities USA LLC. Company insiders that have sold KBL MERGER CORP/SH company stock in the last year include Mizuho Securities Usa Llc, and Oxford Asset Management Llp.
View insider buying and selling activity for KBL MERGER CORP/SH
.

How do I buy shares of KBL MERGER CORP/SH?

Shares of KBLM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is KBL MERGER CORP/SH's stock price today?

One share of KBLM stock can currently be purchased for approximately $10.98.

How big of a company is KBL MERGER CORP/SH?

KBL MERGER CORP/SH has a market capitalization of $48.53 million.

What is KBL MERGER CORP/SH's official website?

The official website for KBL MERGER CORP/SH is www.kblmerger.com.

How can I contact KBL MERGER CORP/SH?

KBL MERGER CORP/SH's mailing address is 30 PARK PLACE SUITE 45E, NEW YORK NY, 10007. The company can be reached via phone at 302-502-2727.

This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.